Last reviewed · How we verify
Control tetanus vaccine, adsorbed — Competitive Intelligence Brief
phase 3
Inactivated bacterial toxoid vaccine
Tetanus toxin (tetanospasmin)
Immunology / Infectious Disease
Biologic
Live · refreshed every 30 min
Target snapshot
Control tetanus vaccine, adsorbed (Control tetanus vaccine, adsorbed) — Sinovac Life Sciences Co., Ltd.. This vaccine stimulates the immune system to produce antibodies against tetanus toxin by presenting inactivated tetanus toxoid adsorbed onto an aluminum salt adjuvant.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Control tetanus vaccine, adsorbed TARGET | Control tetanus vaccine, adsorbed | Sinovac Life Sciences Co., Ltd. | phase 3 | Inactivated bacterial toxoid vaccine | Tetanus toxin (tetanospasmin) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Inactivated bacterial toxoid vaccine class)
- Sinovac Life Sciences Co., Ltd. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Control tetanus vaccine, adsorbed CI watch — RSS
- Control tetanus vaccine, adsorbed CI watch — Atom
- Control tetanus vaccine, adsorbed CI watch — JSON
- Control tetanus vaccine, adsorbed alone — RSS
- Whole Inactivated bacterial toxoid vaccine class — RSS
Cite this brief
Drug Landscape (2026). Control tetanus vaccine, adsorbed — Competitive Intelligence Brief. https://druglandscape.com/ci/control-tetanus-vaccine-adsorbed. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab